One of the more cumbersome tasks for study teams is to manage the user administration and provisioning process into all of the technologies used to conduct clinical trials today. ePharmaSolutions has developed a solution to streamline this process to one set of credentials and one technology solution regardless of the number of vendors involved in a given study.
"The Vendor Integration Manager (VIM) is now being used on dozens of studies and provides study teams with a single user interface to manage the user provisioning process," stated Lance Converse, ePharmaSolutions founder and CEO. "Our clients complained about the need to complete up to 10 different spreadsheets each time a user is added or edited through the study, which on large studies is a difficult task that is ridden with errors," Converse added.
A typical clinical study can require up to 10 unique technology vendors that each has their own account activation and user provisioning forms and processes. This is cumbersome for clinical study managers conducting large studies who are required to complete these forms each time a user is added or edited throughout a study. For larger studies, access control to as many as 4,000 unique users in 10 systems with different roles and naming conventions must be maintained and updated in a validated environment.
"The Vendor Integration Manager works as the system of record for each user in the study and auto-completes each technology vendor's user account provisioning forms in the exact format and process they require saving study teams an enormous amount of time and avoiding countless mistakes," Converse said.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.